These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 27259484

  • 1. Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients.
    Hayashi Y, Takagi M, Kakihara J, Sakamoto S, Doi A, Sugioka K, Hanatani A, Yoshiyama M.
    Heart Vessels; 2017 Feb; 32(2):175-185. PubMed ID: 27259484
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study).
    Mastenbroek MH, Pedersen SS, van der Tweel I, Doevendans PA, Meine M.
    Am J Cardiol; 2016 Feb 15; 117(4):596-604. PubMed ID: 26732419
    [Abstract] [Full Text] [Related]

  • 6. Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.
    Gasparini M, Lunati MG, Proclemer A, Arenal A, Kloppe A, Martínez Ferrer JB, Hersi AS, Gulaj M, Wijffels MCE, Santi E, Manotta L, Varma N.
    JACC Clin Electrophysiol; 2017 Nov 15; 3(11):1275-1282. PubMed ID: 29759624
    [Abstract] [Full Text] [Related]

  • 7. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B, Kühne M, Reichlin T, Osswald S, Sticherling C.
    Europace; 2016 Feb 15; 18(2):227-31. PubMed ID: 26063686
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.
    Bozyel S, Aktas M, Mutluer FO, Guler TE, Dervis E, Argan O, Celikyurt U, Agir A, Vural A.
    Acta Cardiol; 2019 Jun 15; 74(3):246-251. PubMed ID: 30058473
    [Abstract] [Full Text] [Related]

  • 10. Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS bY InCreaseD zones) trial.
    Cay S, Canpolat U, Ucar F, Ozeke O, Ozcan F, Topaloglu S, Aras D.
    Am J Cardiol; 2015 May 01; 115(9):1235-43. PubMed ID: 25765588
    [Abstract] [Full Text] [Related]

  • 11. Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.
    Schwab JO, Bonnemeier H, Kleemann T, Brachmann J, Fischer S, Birkenhauer F, Eberhardt F.
    Clin Res Cardiol; 2015 Dec 01; 104(12):1021-32. PubMed ID: 26002818
    [Abstract] [Full Text] [Related]

  • 12. Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks.
    Silver MT, Sterns LD, Piccini JP, Joung B, Ching CK, Pickett RA, Rabinovich R, Liu S, Peterson BJ, Lexcen DR, Shock-Less Investigators.
    Heart Rhythm; 2015 Mar 01; 12(3):545-553. PubMed ID: 25460168
    [Abstract] [Full Text] [Related]

  • 13. Extended detection time to reduce shocks is safe in secondary prevention patients: The secondary prevention substudy of PainFree SST.
    Sterns LD, Meine M, Kurita T, Meijer A, Auricchio A, Ando K, Leng CT, Okumura K, Sapp JL, Brown ML, Lexcen DR, Gerritse B, Schloss EJ.
    Heart Rhythm; 2016 Jul 01; 13(7):1489-96. PubMed ID: 26988379
    [Abstract] [Full Text] [Related]

  • 14. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA, Link MS, Semsarian C, Shen WK, Estes NA, Maron MS, Haas TS, Formisano F, Boriani G, Spirito P, Maron BJ.
    Heart Rhythm; 2013 Feb 01; 10(2):214-8. PubMed ID: 23041573
    [Abstract] [Full Text] [Related]

  • 15. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F, Palmisano P, Dell'Era G, Ziacchi M, Ammendola E, Bonelli P, Patani F, Cupido C, Devecchi C, Accogli M, Occhetta E, Santangelo L, Biffi M, Boriani G, Capucci A, Italian Association of Arrhythmology and Cardiac Pacing (AIAC).
    Heart Rhythm; 2016 Oct 01; 13(10):1987-92. PubMed ID: 27291511
    [Abstract] [Full Text] [Related]

  • 16. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
    Wilkoff BL, Hess M, Young J, Abraham WT.
    J Cardiovasc Electrophysiol; 2004 Sep 01; 15(9):1002-9. PubMed ID: 15363071
    [Abstract] [Full Text] [Related]

  • 17. [Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome].
    Binbin Y, Jingping L, Bing Y, Minglong C, Jiangang Z, Kejiang C, Qijun S.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug 01; 43(8):690-4. PubMed ID: 26955725
    [Abstract] [Full Text] [Related]

  • 18. Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy).
    Biton Y, Huang DT, Goldenberg I, Rosero S, Moss AJ, Kutyifa V, McNitt S, Strasberg B, Zareba W, Barsheshet A.
    Heart Rhythm; 2016 Apr 01; 13(4):888-93. PubMed ID: 26711799
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH, Lin YJ, Huang JL, Wu TJ, Cheng CC, Lin WS, Tuan TC, Chang SL, Lo LW, Hu YF, Chao TF, Chung FP, Tsai CF, Tsao HM, Chen SA.
    J Cardiovasc Electrophysiol; 2012 Jul 01; 23(7):750-6. PubMed ID: 22353378
    [Abstract] [Full Text] [Related]

  • 20. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, Cannom DS, Estes NA, Ruwald MH, Huang DT, Klein H, McNitt S, Beck CA, Goldstein R, Brown MW, Kautzner J, Shoda M, Wilber D, Zareba W, Daubert JP.
    Circ Arrhythm Electrophysiol; 2014 Oct 01; 7(5):785-92. PubMed ID: 25136077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.